Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Cardiac Arrhythmia Network of Canada | OTHER |
Not provided
Not provided
Not provided
Not provided
This multicentre prospective cohort trial is designed to demonstrate effectiveness and efficiency of a virtual care model for the management of COVID-19 patients isolating at home. The investigators have reoriented existing technology and networks for this research project. The investigators are amplifying our existing virtual care platform VIRTUES, combining it with home monitoring of COVID-19 patients, to provide real-time evidence, harmonize data collection, and share data provincially to mitigate the impact of the rapid spread of the virus. The study will facilitate early detection of complications associated with the disease, treatment and management of COVID-19 patients at home. The research will be conducted provincially in Ontario.
This initiative will provide evidence to inform clinical and health system management and public health response to COVID-19 patients isolating at home.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| COVID-19 Virtual Care at Home | Other | VIRTUES COVID-19 Care at Home Platform The components of the platform will include:
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Virtual Care at Home | Other | Participants will have access to the VIRTUES platform for COVID-19 Virtual Care at Home |
|
| Measure | Description | Time Frame |
|---|---|---|
| 14 Day Patient Satisfaction Questionnaire | The primary outcome measure is patient satisfaction as measured from a patient satisfaction questionnaire at 14 days. | 14 days |
| Measure | Description | Time Frame |
|---|---|---|
| Emergency Department Visits | The secondary outcome measures will include the number of patients that require an Emergency Department visits during the observation period of 14 days. | 14 days |
| 14 Day EQ-5D-5L Scores |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| St. Mary's General Hospital | Kitchener | Ontario | Canada | |||
| London Health Sciences Centre |
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| D017060 | Patient Satisfaction |
| D001008 | Anxiety Disorders |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
Prospective non-randomized cohort study
Not provided
Not provided
Not provided
Not provided
The secondary outcome measures will include the health status measures of the EuroQuality of Life Five Dimensions (EQ-5D-5L) at 14 days. Scoring is Level 1 to 5 for each dimension; higher scores meaning worse health status.
| 14 days |
| London |
| Ontario |
| N6A5A5 |
| Canada |
| Ottawa Heart Research Institute | Ottawa | Ontario | Canada |
| Niagara Health | St. Catharines | Ontario | L2S 0A9 | Canada |
| St. Joseph's Health Centre | Toronto | Ontario | M6R1B5 | Canada |
| D014777 |
| Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
| D001519 | Behavior |
| D001523 | Mental Disorders |